Košík

0474823 - ÚEB 2018 RIV GB eng J - Článek v odborném periodiku
Temml, V. - Garscha, U. - Romp, E. - Schubert, G. - Gerstmeier, J. - Kutil, Zsófia - Matuszczak, B. - Waltenberger, B. - Stuppner, H. - Werz, O. - Schuster, D.
Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening.
Scientific Reports. Roč. 7, FEB 20 (2017), č. článku 42751. ISSN 2045-2322. E-ISSN 2045-2322
Institucionální podpora: RVO:61389030
Klíčová slova: activating protein * drug discovery * leukotriene biosynthesis * inflammatory diseases * conformer generation * arachidonic-acid * flap * challenges * asthma * risk
Obor OECD: Physiology (including cytology)
Impakt faktor: 4.122, rok: 2017
Trvalý link: http://hdl.handle.net/11104/0271773